These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35380462)

  • 1. Glby, Encoded by
    Galanis C; Maggioncalda EC; Kumar P; Lamichhane G
    J Bacteriol; 2022 May; 204(5):e0004622. PubMed ID: 35380462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of
    Ignatius EH; Rimal B; Panthi CM; Belz DC; Lippincott CK; Deck DH; Serio AW; Lamichhane G
    mSphere; 2024 Jul; 9(7):e0038124. PubMed ID: 38980071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease.
    Rimal B; Panthi CM; Xie Y; Belz DC; Ignatius EH; Lippincott CK; Deck DH; Serio AW; Lamichhane G
    Tuberculosis (Edinb); 2024 May; 146():102482. PubMed ID: 38364332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T405, a New Penem, Exhibits
    Rimal B; Batchelder HR; Story-Roller E; Panthi CM; Tabor C; Nuermberger EL; Townsend CA; Lamichhane G
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0053622. PubMed ID: 35638855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease.
    Rimal B; Nicklas DA; Panthi CM; Lippincott CK; Belz DC; Ignatius EH; Deck DH; Serio AW; Lamichhane G
    mSphere; 2023 Apr; 8(2):e0066522. PubMed ID: 36912629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of epetraborole against
    Rimal B; Lippincott CK; Panthi CM; Xie Y; Keepers TR; Alley M; Lamichhane G
    Antimicrob Agents Chemother; 2024 Aug; 68(8):e0064824. PubMed ID: 39016592
    [No Abstract]   [Full Text] [Related]  

  • 7. Clofazimine as a comparator for preclinical efficacy evaluations of experimental therapeutics against pulmonary M. abscessus infection in mice.
    Sriram D; Wahi R; Maggioncalda EC; Panthi CM; Lamichhane G
    Tuberculosis (Edinb); 2022 Dec; 137():102268. PubMed ID: 36228452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microevolution of a Mycobacteroides abscessus subsp. bolletii strain in a clinical persistent infection.
    Santos A; Pinto M; Carneiro S; Silva S; Rodrigues I; Munhá J; Gomes JP; Macedo R
    Infect Genet Evol; 2023 Aug; 112():105437. PubMed ID: 37100339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates
    Nicklas DA; Maggioncalda EC; Story-Roller E; Eichelman B; Tabor C; Serio AW; Keepers TR; Chitra S; Lamichhane G
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0170421. PubMed ID: 34662184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arabinosyltransferase C Mediates Multiple Drugs Intrinsic Resistance by Altering Cell Envelope Permeability in Mycobacterium abscessus.
    Wang S; Cai X; Yu W; Zeng S; Zhang J; Guo L; Gao Y; Lu Z; Hameed HMA; Fang C; Tian X; Yusuf B; Chhotaray C; Alam MDS; Zhang B; Ge H; Maslov DA; Cook GM; Peng J; Lin Y; Zhong N; Zhang G; Zhang T
    Microbiol Spectr; 2022 Aug; 10(4):e0276321. PubMed ID: 35946941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Lactam Combinations That Exhibit Synergy against Mycobacteroides abscessus Clinical Isolates.
    Story-Roller E; Galanis C; Lamichhane G
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33361310
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
    Rominski A; Schulthess B; Müller DM; Keller PM; Sander P
    J Antimicrob Chemother; 2017 Nov; 72(11):3070-3078. PubMed ID: 28961987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam Action.
    Dousa KM; Nguyen DC; Kurz SG; Taracila MA; Bethel CR; Schinabeck W; Kreiswirth BN; Brown ST; Boom WH; Hotchkiss RS; Remy KE; Jacono FJ; Daley CL; Holland SM; Miller AA; Bonomo RA
    mBio; 2022 Feb; 13(1):e0352921. PubMed ID: 35073757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against
    Dousa KM; Shin E; Kurz SG; Plummer M; Nantongo M; Bethel CR; Taracila MA; Nguyen DC; Kreiswith BN; Daley CL; Remy KE; Holland SM; Bonomo RA
    mBio; 2024 Jun; 15(6):e0060924. PubMed ID: 38742824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Products Lysobactin and Sorangicin A Show
    Sullivan JR; Yao J; Courtine C; Lupien A; Herrmann J; Müller R; Behr MA
    Microbiol Spectr; 2022 Dec; 10(6):e0267222. PubMed ID: 36342177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parotitis caused by Mycobacteroides abscessus subspecies abscessus.
    Yonekawa A; Miyake N; Minami J; Murakami D; Fukano H; Hoshino Y; Kubo K; Chong Y; Akashi K; Shimono N
    Auris Nasus Larynx; 2022 Jun; 49(3):525-528. PubMed ID: 33246745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of novel double-reporter strains of
    Bento CM; van Calster K; Piller T; Oliveira GS; de Vooght L; Cappoen D; Cos P; Gomes MS; Silva T
    Microbiol Spectr; 2024 Oct; 12(10):e0036224. PubMed ID: 39189762
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of a penem antibiotic against Mycobacteroides abscessus.
    Batchelder HR; Story-Roller E; Lloyd EP; Kaushik A; Bigelow KM; Maggioncalda EC; Nuermberger EL; Lamichhane G; Townsend CA
    Commun Biol; 2020 Dec; 3(1):741. PubMed ID: 33288821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of LpqM proteins in
    Boudehen Y-M; Daher W; Roquet-Baneres F; Kremer L
    Microbiol Spectr; 2024 May; 12(5):e0383723. PubMed ID: 38619262
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined Host- and Pathogen-Directed Therapy for the Control of Mycobacterium abscessus Infection.
    Poerio N; Riva C; Olimpieri T; Rossi M; Lorè NI; De Santis F; Henrici De Angelis L; Ciciriello F; D'Andrea MM; Lucidi V; Cirillo DM; Fraziano M
    Microbiol Spectr; 2022 Feb; 10(1):e0254621. PubMed ID: 35080463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.